Ipilimumab
About Ipilimumab
Ipilimumab is a specialized immunotherapy medicine prescribed to treat certain advanced cancers, such as melanoma (skin cancer). Its primary medical purpose is to help your body's immune system recognize and fight cancer cells that have spread or cannot be removed by surgery.
This medicine is administered as an intravenous infusion, typically given every few weeks as scheduled by your oncologist. Keeping all your appointments consistently is vital to ensure the treatment works effectively to control tumor growth. Since this is an injection, you do not need to worry about taking it with food, but staying hydrated and eating a balanced diet can greatly support your body's energy levels during treatment.
While receiving Ipilimumab, you may experience common side effects like mild tiredness, skin itching, or diarrhea. However, because it activates your immune system, it can sometimes cause your body to attack its own healthy tissues, leading to serious complications. If you experience severe stomach pain, persistent diarrhea, yellowing of the skin, or shortness of breath, you must contact your doctor immediately.
Talk to your doctor before starting this medicine if you have a history of autoimmune diseases like lupus or inflammatory bowel disease. Do not take this if you have had a severe, life-threatening allergic reaction to Ipilimumab or any of its inactive ingredients in the past. It is also important to share if you have pre-existing liver damage or chronic lung issues.
Certain medications, such as high-dose steroids, can interfere with how this medicine works by suppressing your immune system. Pregnant or breastfeeding individuals should not use this drug because it can harm the developing baby, and elderly patients should consult their healthcare team to closely monitor their tolerance.
Uses of Ipilimumab
Medicinal Benefits
When used as prescribed, Ipilimumab offers several important benefits in the treatment of advanced cancers.
- Strengthens the immune response against cancer: This medicine activates your immune system, helping it recognize and destroy cancer cells more effectively.
- Helps slow cancer progression: By improving your body's immune response, Ipilimumab can slow the growth and spread of certain cancers.
- Provides durable responses in some patients: Some people continue to benefit from treatment for a prolonged period, even after therapy has been completed.
- Improves quality of life: By controlling tumour growth, this medicine may reduce cancer-related symptoms and help many patients maintain their daily activities for longer.
Directions for Use
- Follow your doctor's instructions on the dosage and timing of this medication.
- Ipilimumab will be administered by a nurse or doctor.
- Do not self-administer.
Storage
Side Effects of Ipilimumab
Common Side Effects (Usually mild):
- Fatigue or weakness
- Skin rash, itching, or dry skin
- Diarrhoea
- Nausea
- Decreased appetite
- Muscle or joint pain
- Fever
Serious Side Effects (Consult your doctor right away):
- Persistent or severe diarrhoea, severe abdominal pain, or blood in the stool (possible inflammation of the bowel)
- Yellowing of the skin or eyes, dark urine, or severe upper abdominal pain (possible liver inflammation)
- New or worsening cough, chest pain, or difficulty breathing (possible lung inflammation)
- Severe skin rash, blistering, peeling skin, or painful sores in the mouth
- Severe headaches, confusion, dizziness, vision changes, extreme fatigue, unusual weight changes, increased thirst, or rapid heartbeat (possible hormone gland disorders)
- Reduced urine output, swelling of the legs, or blood in the urine (possible kidney inflammation)
- Severe allergic or infusion-related reactions, including swelling of the face, lips, tongue, or throat, wheezing, or difficulty breathing
Drug Warnings
- Attend all scheduled blood tests: Regular monitoring helps detect immune-related side effects affecting the liver, kidneys, lungs, thyroid, adrenal glands, and other organs.
- Do not ignore persistent diarrhoea: Diarrhoea or abdominal pain can be an early sign of serious inflammation of the bowel. Contact your doctor immediately if these symptoms develop or worsen.
- Tell your doctor about any new symptoms: Even mild symptoms such as a persistent cough, skin rash, severe tiredness, headaches, or vision changes may indicate immune-related side effects and should be assessed promptly.
- Inform every healthcare provider that you are receiving immunotherapy: This is especially important before surgery, dental procedures, vaccinations, or starting new medicines.
- Avoid live vaccines during treatment: Consult your doctor before receiving any vaccination while you are being treated with Ipilimumab.
- Pregnancy warning: Use effective contraception during treatment and for at least 3 months after your final dose. Do not breastfeed during treatment or for 3 months after the last dose.
- Do not self-treat side effects: Avoid taking corticosteroids or other medicines for treatment-related side effects unless directed by your healthcare provider, as they require careful medical supervision.
- When to seek urgent medical care: Seek immediate medical attention if you develop severe breathing difficulty, chest pain, confusion, severe allergic reactions, yellowing of the skin or eyes, or rapidly worsening symptoms.
Drug Interactions
- Systemic corticosteroids and immunosuppressants: High-dose corticosteroids or other medicines that suppress the immune system may reduce the effectiveness of ipilimumab when used before or during treatment. However, your doctor may prescribe these medicines to treat serious immune-related side effects.
- Other anticancer medicines: When used together with nivolumab or certain chemotherapy medicines, the risk of side effects may increase. Your healthcare team will monitor you closely throughout treatment.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorIt is unknown whether Ipilimumab interacts with alcohol. Consult your doctor.
Pregnancy
unsafeIpilimumab is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Ipilimumab. You should not become pregnant while you are taking Ipilimumab for at least 3 months from the last dose of Ipilimumab. Using effective birth control methods while on treatment with Ipilimumab is suggested.
Breast Feeding
unsafeInform your doctor if you are intending to breastfeed. Breastfeeding should be avoided while getting Ipilimumab and for 3 months following the final dosage.
Driving
not applicableIpilimumab will be administered to hospitalized patients.
Liver
cautionIf you have a pre-existing or a history of liver problems, tell your doctor before taking this medicine. Ipilimumab is known to cause hepatotoxicity when taken in combination with nivolumab. Notify your doctor if you notice any of the following symptoms: yellowing of your skin or whites of your eyes; severe nausea or vomiting; pain on the right side of your stomach (abdomen); dark urine (tea-coloured); easier bleeding or bruising than usual. Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.
Kidney
cautionIf you have a pre-existing or a history of kidney diseases, inform your doctor before taking Ipilimumab. It may cause kidney injury. Notify your doctor if you experience symptoms such as decreased urine output, blood in your urine, ankle edema, or lack of appetite.
Children
unsafeIpilimumab is not recommended for use in children below 12 years, as the safety and efficacy have not been established.
Habit Forming
Diet & Lifestyle Advise
- Eat a balanced diet: Choose nutritious meals rich in fruits, vegetables, whole grains, and lean protein to help support your body during cancer treatment.
- Stay well-hydrated: Drink plenty of fluids unless your doctor advises otherwise, especially if you experience diarrhoea or reduced appetite.
- Protect your skin: Use mild, fragrance-free moisturisers and broad-spectrum sunscreen, as skin rash and itching are common during treatment.
- Stay active as tolerated: Gentle activities such as walking or stretching may help reduce fatigue and maintain muscle strength. Balance activity with adequate rest.
- Report new symptoms promptly: Even mild symptoms can become serious if they are caused by an overactive immune system. Contact your healthcare provider without delay if you notice persistent diarrhoea, cough, skin rash, vision changes, or unusual fatigue.
- Keep all follow-up appointments: Regular blood tests and medical reviews help detect immune-related side effects early and monitor your response to treatment.
Special Advise
- Your doctor may suggest periodic liver function tests, kidney function tests, and lung function tests to monitor the function of the liver, kidney and lungs due to the use of Ipilimumab.
- Using contraceptive pills while using Ipilimumab to prevent pregnancy is advised.
- Thyroid function and adrenocorticotropic hormone levels will be monitored during treatment to avoid any life-threatening side effects.
Patients Concern
Disease/Condition Glossary
Renal Cell Carcinoma: Also known as kidney cancer. It is the most common type of cancer seen in adults. This condition occurs when cancer/ malignant cells grow uncontrollably in the kidney and form a tumor. Advanced kidney cancer (metastatic renal cell carcinoma) occurs when the malignant cells spread to other parts of the body. Symptoms include red, orange, or pink-coloured urine due to the presence of blood in the urine.
Hepatocellular carcinoma: Also known as liver cancer. It occurs when the cancer/ malignant cells grow out of control. This infects the liver, destroys the liver cells and affects the ability of the liver to work properly. Symptoms may include abdominal pain, loss of appetite, weight loss, and pale bowel motions.
Colorectal cancer: Also known as colon cancer (growth of cancer cells in the colon) or rectal cancer (cancer cells grow in the rectum area), is a condition in which the cancerous or malignant cells grow out of control in the colon or rectum. Symptoms may include diarrhoea, constipation, bloody stools, change in bowel habits, abdominal discomfort, etc.
Metastatic Malignant Melanoma: Melanoma is a type of skin cancer in which the cancer cells grow in melanocytes. It is mainly caused by harmful UV radiation from the sun. When the cancer cells spread to other parts of the body, it is known as Metastasis. Malignant melanoma is common in fair-skinned and freckled individuals. It results in mole formation, typically on the skin of the face.
Malignant pleural mesothelioma: It is a type of cancer that develops in the mesothelium (a lining that covers the outer surface of organs), predominantly caused by exposure to asbestos. Symptoms of mesothelioma in the lining of the lungs include chest pain, shortness of breath, extreme tiredness, persistent cough, loss of appetite, unexplained weight loss, fever and sweating, particularly at night.
Non-Small Cell Lung Cancer (NSCLC): Lung cancer is defined as an uncontrollable growth of abnormal cells in one or both lungs. These abnormal cells disturb lung cell functions and do not develop into healthy lung tissue. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Cancerous cells of the lung spread off and travel through the bloodstream to distant regions of the body and grow. It is mostly seen in persons who smoke. Symptoms may include chest pain, weight loss, hoarseness, and difficulty breathing.
FAQs
Ipilimumab treats various cancers, including Renal Cell Carcinoma, Hepatocellular carcinoma, Colorectal Cancer, Metastatic Melanoma, metastatic non-small cell lung cancer, and Malignant pleural mesothelioma.
Ipilimumab contains Ipilimumab, which works by inhibiting the action of a human cytotoxic T-lymphocyte antigen-4 (CTLA-4) molecule that causes the multiplication of cancerous cells.
It is safe to use Ipilimumab in patients with diabetes. However, if you are diabetic, inform your doctor before starting the treatment with Ipilimumab.
Ipilimumab is given as an intravenous (IV) infusion directly into a vein. It is administered in a hospital or clinic by trained healthcare professionals. Talk to your doctor for more details.
Some patients feel very tired or weak after their infusion. If you experience these side effects, you should avoid driving or operating machinery. Talk to your doctor or pharmacist.
No, Ipilimumab is an immunotherapy, not chemotherapy. Chemotherapy directly targets and kills rapidly dividing cells, while immunotherapy helps your own immune system recognize and destroy cancer cells. Talk to your doctor.
There is no direct interaction between alcohol and Ipilimumab, but alcohol can worsen fatigue, dehydration, and liver strain. It is best to limit or avoid alcohol. Talk to your doctor.
Rashes are common but can sometimes become severe. You should notify your healthcare team immediately so they can evaluate the rash and prescribe safe treatments. Talk to your doctor.
No, you should not get pregnant during treatment, as Ipilimumab can harm an unborn baby. Use effective birth control during treatment and for at least 3 months after your last dose. Talk to your doctor.
